Browse Drug Recalls
2,002 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 2,002 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 2,002 FDA drug recalls.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Jul 23, 2012 | Mercaptopurine Tablets, USP, 50 mg, 30 Tablets (3 x 10) unit dose blisters pe... | Failed USP Dissolution Test Requirements: This sub-recall is in response to Prometheus Laboratori... | Class II | American Health Packaging |
| Jul 18, 2012 | Walgreens ASPIRIN FREE TENSION HEADACHE, Pain Reliever/Pain Reliever Aid, Ace... | Incorrect/Undeclared Excipients: The firm recalled specific lots of Walgreens brand Aspirin Free ... | Class II | LNK International, Inc. |
| Jul 18, 2012 | Fougera Ketoconazole Cream 2%, 15g tube, Rx only, Labeled with E. Fougera & C... | Failed Impurities/Degradation Specifications: Ketoconazole Cream 2% is the subject of a voluntary... | Class III | Fougera Pharmaceuticals Inc. |
| Jul 16, 2012 | X-ROCK 3 Day Pill For Men, supplied in 1 and 2 capsule blister packs and 6, 1... | Marketed Without an Approved NDA/ANDA: Products tested positive for Sildenafil and analogs of Sil... | Class I | Coral Rock Man, Inc. |
| Jul 13, 2012 | CosMedix Serious Protection, Natural SPF 28 Sunscreen, 3.3 fl.oz/100mL (100 g... | Microbial Contamination of Non Sterile Product; mold | Class II | Island Kinetics dba Covalence |
| Jul 12, 2012 | Major brand Infants' Mapap, Acetaminophen Concentrated Drops, 1 FL. OZ. (30 m... | Labeling; labeled with incorrect EXP Date; Incorrect expiration date printed on the outer packagi... | Class III | Axcentria Pharmaceuticals LLC |
| Jul 9, 2012 | Thyro-Tab 0.137 mg., packaged in 150,000-tablet bulk drums for repackaging, R... | cGMP Deviations; does not meet in process specification requirements | Class II | Lloyd Inc. of Iowa |
| Jul 9, 2012 | Thyro-Tab 0.050 mg., packaged in 150,000-tablet bulk drums for repackaging, R... | cGMP Deviations; does not meet in process specification requirements | Class II | Lloyd Inc. of Iowa |
| Jul 9, 2012 | Thyro-Tab 0.112 mg., packaged in 150,000-tablet bulk drums for repackaging, R... | cGMP Deviations; does not meet in process specification requirements | Class II | Lloyd Inc. of Iowa |
| Jul 9, 2012 | Thyro-Tab 0.125 mg., packaged in 150,000-tablet bulk drums for repackaging, R... | cGMP Deviations; does not meet in process specification requirements | Class II | Lloyd Inc. of Iowa |
| Jul 9, 2012 | Thyro-Tab 0.300 mg., packaged in 150,000-tablet bulk drums for repackaging, R... | cGMP Deviations; does not meet in process specification requirements | Class II | Lloyd Inc. of Iowa |
| Jul 9, 2012 | Thyro-Tab 0.088 mg., packaged in 150,000-tablet bulk drums for repackaging, R... | cGMP Deviations; does not meet in process specification requirements | Class II | Lloyd Inc. of Iowa |
| Jul 6, 2012 | NAPROXEN TABLETS USP, 500 mg, 100-count Tablets per bottle, Rx only, Manufact... | Labeling: Label Mix-Up: Bottles labeled as Naproxen Tablets USP, 500 mg, 100-count may contain 90... | Class II | Glenmark Generics Inc., USA |
| Jun 28, 2012 | Super Colon Cleanse, stimulant laxative, 140 mg of Senna per capsule, 25 dose... | Labeling: Label Mix-up: The product is being recalled because active ingredient in the Drug Fact... | Class III | Health Plus Incorporated |
| Jun 27, 2012 | Carboplatin Injection, 10 mg/mL, 45 mL Multi-Dose Vial, Rx only, antineoplas... | The affected lots of Carboplatin Injection, Cytarabine Injection, Methotrexate Injection, USP, a... | Class II | Hospira Inc. |
| Jun 18, 2012 | Tobramycin Ophthalmic Oint., 0.3%, 5ml bottle, (Generic for: Tobrex), Rx only... | Labeling: Label Mix-up: The affected units were labeled incorrectly describing the product as "oi... | Class III | Stat Rx USA |
| Jun 14, 2012 | Dukal Corporation BZK Swab, First Aid Antiseptic, (Benzalkonium Chloride), 0.... | Microbial contamination of Non Sterile Product; contamination with Burkholderia cepacia (manufact... | Class II | Dukal Corp. |
| Jun 5, 2012 | Kombiglyze XR (saxagliptin and metformin HCl extended-release) tablets, Physi... | Labeling; Correct labeled product miscart/mispack: Some Physician sample cartons were incorrectly... | Class II | Bristol-myers Squibb Company |
| Jun 5, 2012 | Pitocin (Oxytocin Injection, USP) Synthetic 10 units per mL 10 mL, Rx only, M... | Labeling: Label Mix-up: Pitocin storage conditions should be labeled, "Store between 20¿ to 25¿C ... | Class III | JHP Pharmaceuticals, LLC |
| Jun 5, 2012 | Kombiglyze XR (saxagliptin and metformin HCl extended-release) tablets, Physi... | Labeling; Correct labeled product miscart/mispack: Some Physician sample cartons were incorrectly... | Class II | Bristol-myers Squibb Company |
| May 21, 2012 | Hands Down Medicated Lotion Soap, 1 gallon bottle, 4 gallons per case, Distri... | Labeling: Presence of Undeclared Additive: Medicated lotion soap produced and distributed by the ... | Class II | Kutol Products Co Inc |
| May 12, 2012 | HYDROmorphone HCl Injection, USP, 1 mg/mL, 1 mL fill in a 2.5 mL Carpuject pr... | Superpotent (Single Ingredient) Drug: Some of the prefilled cartridge units have been found to be... | Class I | Hospira Inc. |
| Apr 26, 2012 | Midol Complete, Acetaminophen, Caffeine, Pyrilamine Maleate, Gelcaps 24 ct. b... | Labeling: Label Mix-up: This recall was initiated after identifying that the label statement on t... | Class III | Bayer Healthcare, LLC |
| Apr 26, 2012 | Midol Complete, Acetaminophen, Caffeine, Pyrilamine Maleate, Caplets, OTC, a)... | Labeling: Label Mix-up: This recall was initiated after identifying that the label statement on t... | Class III | Bayer Healthcare, LLC |
| Apr 21, 2012 | X-ROCK For Men, Dietary Supplement, Manufactured by CRM Laboratories, Distri... | Marketed Without an Approved NDA/ANDA: product tested positive for PDE-5 Sildenafil and PDE-5 Hyd... | Class I | XRock Industries, LLC |
| Apr 17, 2012 | Loxapine Capsules USP, 5mg, 100 count bottle, Rx only Manufactured By: Watson... | Labeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used... | Class III | Watson Laboratories Inc |
| Apr 17, 2012 | Loxapine Capsules USP, 50mg, 100 count bottle, Rx only Manufactured By: Watso... | Labeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used... | Class III | Watson Laboratories Inc |
| Apr 17, 2012 | Loxapine Capsules USP, 10mg, 100 count bottle, Rx only, Manufactured By: Wats... | Labeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used... | Class III | Watson Laboratories Inc |
| Apr 17, 2012 | Morphine Sulfate Injection, USP, 4mg/mL, 1 mL fill in 2.5 mL Carpuject Cartr... | Superpotent; Cartridges labeled to contain 1 mL found to contain 2.2 mL | Class I | Hospira Inc. |
| Apr 17, 2012 | Loxapine Capsules USP, 25mg, 100 count bottle, Rx only, Manufactured By: Wats... | Labeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used... | Class III | Watson Laboratories Inc |
| Apr 17, 2012 | Loxitane Capsules, Loxapine Succinate Capsules, 10mg base, 100 count bottle,... | Labeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used... | Class III | Watson Laboratories Inc |
| Apr 13, 2012 | Fosphenytoin Sodium Injection, USP, 500 mg PE per 10 mL (50 mg PE per mL), 10... | Presence of Particulate Matter: This product is being recalled due to the discovery of particles ... | Class II | West-ward Pharmaceutical Corp. |
| Apr 13, 2012 | Fosphenytoin Sodium Injection, USP, 100 mg PE per 2 mL (50 mg PE per mL), 2 m... | Presence of Particulate Matter: This product is being recalled due to the discovery of particles ... | Class II | West-ward Pharmaceutical Corp. |
| Apr 9, 2012 | Dr. Reddy's Amlodipine Besylate and Benazepril Hydrochloride 5 mg*/20 mg, 50... | Adulterated Presence of Foreign Tablets: Dr. Reddy's Laboratories has received complaints of misl... | Class II | Dr. Reddy's Laboratories, Inc. |
| Apr 9, 2012 | Dr. Reddy's Ciprofloxacin Tablets, USP 500 mg*, 500 Tablets, Rx only, Mfd. By... | Adulterated Presence of Foreign Tablets: Dr. Reddy's Laboratories has received complaints of misl... | Class II | Dr. Reddy's Laboratories, Inc. |
| Mar 20, 2012 | DermaZinc Spray, 0.25% zinc pyritione, topical OTC, 4 fl oz bottle Distribut... | Subpotent (Single Ingredient Drug): The firm is recalling the product because the product is subp... | Class III | Quadrant Chemical Corporation |
| Mar 9, 2012 | Northstar Zolpidem Tartrate Tablets USP 10 mg. Manufactured for Northstar RX... | Adulterated Presence of Foreign Tablets: This product is being recalled becaiuse 30 valacyclovir ... | Class II | Aurobindo Pharma LTD |
| Mar 9, 2012 | Ciprofloxacin Tablets, USP, 500 mg, Rx Only, 100 Tablets per Bottle, Manufact... | Labeling Illegible: Missing Label; The voluntary recall of the aforementioned batch of product is... | Class III | Pack Pharmaceuticals |
| Feb 24, 2012 | Thyro-Tab.075 mg., packaged in bulk drums for repackaging. The firm name on t... | Subpotent (Single Ingredient Drug): Low assay at the 6-month test interval. | Class II | Lloyd Inc |
| Feb 3, 2012 | Thyro-Tab 0.050mg., packaged in bulk drums for repackaging. The firm name on... | Subpotent (Single Ingredient Drug): Low assay at the 9-month test interval. | Class II | Lloyd Inc |
| Oct 17, 2011 | Prefera OB One Gel Capsules, 30 softgels, Rx Only, Manufactured by: IVC indus... | Labeling: Presence of Undeclared Color Additive; The product is being recalled because several in... | Class II | Meda Pharmaceuticals Inc. |
| Sep 27, 2011 | metFORMIN ER Tablets, 500 mg, Rx, Packaged and labeled as metFORMIN Immediate... | Labeling: Label Mix up; product labeled did not indicated Extended Release | Class I | Shamrock Medical Solutions Group LLC |
| Sep 27, 2011 | Docusate Calcium Softgel Capsules, 240 mg, OTC, packaged and labeled to conta... | Labeling: Label Mix up; product labeled to contain Docusate Sodium 240mg instead of Docusate Calc... | Class II | Shamrock Medical Solutions Group LLC |
| Sep 27, 2011 | Oxycodone HCl Oral Concentrate, 20 mg/mL, Rx (C-II) Packaged and labeled as M... | Labeling: Label Mix up; product labeled as Morphine Sulfate 20 mg/mL actually contained OxyCODONE... | Class I | Shamrock Medical Solutions Group LLC |
| Sep 27, 2011 | Taztia XT (Diltiazem HCl) Capsules, 120 mg, Rx, Packaged and labeled as Thiam... | Labeling: Label Mix Up; packages labeled as Thiamine actually contain Diltiazem Capsules | Class I | Shamrock Medical Solutions Group LLC |
| Sep 27, 2011 | Sulfamethoxazole and Trimethoprim Tablets, 800 mg/160 mg, DOUBLE STRENGTH, Rx... | Labeling: Label Mix up; product labeled to contain Sulfamethoxazole and Trimethoprim Tablets, 400... | Class II | Shamrock Medical Solutions Group LLC |
| Sep 27, 2011 | Pramipexole Dihydrochloride Tablets, 0.5 mg, Rx, packaged and labeled to cont... | Labeling: Label Mix up; product labeled to contain Nebivolol tablets actually contained Pramipexo... | Class II | Shamrock Medical Solutions Group LLC |
| Jul 5, 2011 | Daytrana (methylphenidate) transdermal system patch, Delivers 20 mg over 9 ho... | Miscalibrated and/or Defective Delivery System: Out of Specification results for mechanical peel ... | Class II | Noven Pharmaceuticals, Inc. |
| Jan 19, 2011 | METOCLOPRAMIDE ORAL SOLUTION, USP 5 mg/5 mL, This cup delivers 10 mL, Rx Only... | Labeling: Correct Labeled Product Miscart/Mispack: The shipper label displayed "5 mL x 50," inste... | Class III | VistaPharm, Inc. |
| Nov 10, 2010 | Morphine Sulfate Extended Release tablet, 30 mg, 60 tablet bottles, Rx only, ... | Labeling: Label mix-up; Bottles labeled to contain Morphine Sulfate IR may contain Morphine Sulfa... | Class I | Physicians Total Care, Inc |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.